BIO24-029: Predicting Disparities in Adverse Dispositions Following Major Surgery for Lung Cancer Using Machine Learning
Atulya Aman Khosla(Baptist Hospital of Miami), Ishmael Jaiyesimi(Beaumont Hospital, Royal Oak), Mukesh Roy(Baptist Health South Florida), Muni Rubens(Florida International University), Venkataraghavan Ramamoorthy(Baptist Health South Florida), Anshul Saxena(Florida International University), Md Ashfaq Ahmed(Baptist Health South Florida), Aakash Desai(University of Connecticut), Yanjia Zhang(Kunming University of Science and Technology), Rohit Singh(University of Vermont Medical Center), Zhenwei Zhang(Baptist Health South Florida), Nitya Batra(Jacksonville College), Karan Jatwani(Roswell Park Comprehensive Cancer Center), Vijval Rajan(Baptist Health South Florida), Mohammad Arfat Ganiyani(Baptist Hospital of Miami)
Cited by 0
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Non–Small Cell Lung Cancer, Version 4.2024
|Journal of the National Comprehensive Cancer Network|2024|805
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
|Annals of Oncology|2021|328
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
|Nature Reviews Clinical Oncology|2023|296
Mitigating acute chemotherapy-associated adverse events in patients with cancer
|Nature Reviews Clinical Oncology|2022|161